ScholarIQanswers from OpenAlex

Multi-Institution Analysis of Tarlatamab for the Treatment of <i>EGFR</i> -Mutant Transformed Small Cell Lung Cancer

PaperCitations, authors & open-access status

Multi-Institution Analysis of Tarlatamab for the Treatment of <i>EGFR</i> -Mutant Transformed Small Cell Lung Cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Multi-Institution Analysis of Tarlatamab for the Treatment of <i>EGFR</i> -Mutant Transformed Small Cell Lung Cancer have?

ScholarIQcitation count

Multi-Institution Analysis of Tarlatamab for the Treatment of <i>EGFR</i> -Mutant Transformed Small Cell Lung Cancer has 4 citations in the OpenAlex counts ScholarIQ stores.

When was Multi-Institution Analysis of Tarlatamab for the Treatment of <i>EGFR</i> -Mutant Transformed Small Cell Lung Cancer published?

ScholarIQyear

Multi-Institution Analysis of Tarlatamab for the Treatment of <i>EGFR</i> -Mutant Transformed Small Cell Lung Cancer has 2025 year in the ScholarIQ index.

What is the open-access status of Multi-Institution Analysis of Tarlatamab for the Treatment of <i>EGFR</i> -Mutant Transformed Small Cell Lung Cancer?

ScholarIQoa status

Multi-Institution Analysis of Tarlatamab for the Treatment of <i>EGFR</i> -Mutant Transformed Small Cell Lung Cancer has closed oa status in the ScholarIQ index.

What is the DOI of Multi-Institution Analysis of Tarlatamab for the Treatment of <i>EGFR</i> -Mutant Transformed Small Cell Lung Cancer?

ScholarIQdoi

The DOI for Multi-Institution Analysis of Tarlatamab for the Treatment of <i>EGFR</i> -Mutant Transformed Small Cell Lung Cancer is on the source record.

What is the PMID of Multi-Institution Analysis of Tarlatamab for the Treatment of <i>EGFR</i> -Mutant Transformed Small Cell Lung Cancer?

ScholarIQpmid

The PMID for Multi-Institution Analysis of Tarlatamab for the Treatment of <i>EGFR</i> -Mutant Transformed Small Cell Lung Cancer is on the source record.

What is the OpenAlex record for Multi-Institution Analysis of Tarlatamab for the Treatment of <i>EGFR</i> -Mutant Transformed Small Cell Lung Cancer?

ScholarIQopenalex

The OpenAlex for Multi-Institution Analysis of Tarlatamab for the Treatment of <i>EGFR</i> -Mutant Transformed Small Cell Lung Cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial